FIELD: medicine, cardiology.
SUBSTANCE: at the background of conventional therapy with β-blockers, inhibitors of angiotensin converting enzyme, antiaggregants and/or antagonists of calcium it is necessary to introduce monocinque at the dosage of 20 mg once or twice daily in combination with melatonin at the dosage of 3-6 mg once daily nocturnally. The innovation provides normalization of global systolic and diastolic myocardial function due to optimal combination of medicinal preparations introduced at declared schemes and dosages.
EFFECT: higher efficiency of therapy.
1 cl, 2 ex, 9 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ADAPTOGEN FOR METEOSENSITIVE PATIENTS WITH STENOCARDIA AND ARTERIAL HYPERTENSION AND APPLICATION OF MELATONIN AS ADAPTOGEN | 2010 |
|
RU2428183C1 |
| AGENT FOR TREATMENT OF PATIENT WITH ARTERIAL HYPERTENSION, METHOD OF TREATMENT OF PATIENT WITH ARTERIAL HYPERTENSION | 1998 |
|
RU2134108C1 |
| METHOD OF HYPERTENSION TREATMENT | 1993 |
|
RU2072837C1 |
| METHOD OF TREATING PATIENTS WITH ISCHEMIC HEART DISEASE ACCOMPANIED BY HYPERTONIC DISEASE | 2011 |
|
RU2466706C2 |
| METHOD TO MATCH AN EFFECTIVE DOSAGE OF BETA-ADRENOBLOCKERS IN ISCHEMIC PATIENTS | 2000 |
|
RU2180796C1 |
| METHOD OF TREATING PATIENTS WITH CARDIOVASCULAR DISEASES | 2013 |
|
RU2543468C2 |
| METHOD FOR PREDICTING ISCHEMIC CARDIAC DISEASE IN PATIENTS WITH ARTERIAL HYPERTENSION | 2006 |
|
RU2316995C1 |
| METHOD FOR EVALUATING CLINICAL THERAPEUTIC EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION | 2006 |
|
RU2316996C1 |
| METHOD OF TREATING PATIENTS WITH HYPERTENSION DISEASE IN COMBINATION WITH BRONCHIAL ASTHMA | 2009 |
|
RU2411964C1 |
| METHOD OF DIFFERENTIALLY DIAGNOSING PULMONARY COMPLICATIONS IN ACUTE MYOCARDIAL INFARCTION AND ITS VERSIONS | 1993 |
|
RU2112980C1 |
